Praxis Impact Large Cap Value ETF (PRXV) Holdings

이 페이지는 영어 원문에서 AI로 기계 번역되었습니다. 영어 버전이 기준입니다. 영어 버전 읽기

정보 제공만을 목적으로 합니다. 재정적 조언이 아닙니다.

빠른 답변

Praxis Impact Large Cap Value ETF (PRXV) has a last stored price of $36.20, as of the Oct 26, 2026 trading session. It has a 0.36% expense ratio and $54M in assets under management.

Holdings and weights below are as of Mar 15, 2026. In the stored portfolio snapshot, the largest listed holding is JPMorgan Chase & Co (JPM) at 3.50%.

Praxis Impact Large Cap Value ETF (PRXV) ETF — Price, Holdings & Analysis

ETF 개요

The Praxis Impact Large Cap Value ETF (PRXV) aims for capital appreciation by investing in large-cap U.S. companies that display value characteristics. This actively managed ETF distinguishes itself by integrating faith-based equity screens, reflecting Praxis's commitment to stewardship investing principles. The fund's investment approach mirrors quantitative equity strategies found in the Praxis Value Index Fund (MVIIX), employing optimization methods to minimize tracking error relative to the CRSP US Large Cap Value Index. Other notable holdings include Procter & Gamble Co, Micron Technology Inc, and AbbVie Inc. This concentrated portfolio reflects a high-conviction approach within the large-cap value space, appealing to investors seeking value-oriented exposure with a faith-based screening overlay.

위험 지표

PRXV's introduces concentration risk, as a significant portion of the fund's assets are allocated to a small number of companies. For example, the top 10 holdings constitute a substantial percentage of the fund's total assets. The fund's sector exposure, driven by its value focus, may also present sector-specific risks depending on market conditions. With a 3-year Beta of 0.00, PRXV has not demonstrated significant volatility relative to the market. The expense ratio of 0.36% will create a small drag on performance over time, reducing net returns compared to similar ETFs with lower fees. Past performance does not guarantee future results.

베타: 0.00

운용보수율

0.36%

PRXV은(는) 무엇을 보유하고 있나요?

보유 종목	비중
JPMorgan Chase & Co (JPM)	3.50%
Johnson & Johnson (JNJ)	2.65%
Walmart Inc (WMT)	2.36%
Procter & Gamble Co (PG)	2.15%
Micron Technology Inc (MU)	2.02%
AbbVie Inc (ABBV)	1.75%
The Home Depot Inc (HD)	1.63%
Coca-Cola Co (KO)	1.53%
Bank of America Corp (BAC)	1.44%
ConocoPhillips (COP)	1.43%

보유 종목 및 비중: 2026년 3월 15일 기준. 이 펀드 데이터는 45일 이상 지났습니다. 최신 보유 종목은 발행사에서 확인하세요.

배당수익률

0.00%

iShares Morningstar Small-Cap Growth ETF (JKK) — 0.06% expense ratio
ARK Innovation ETF (ARKK) — 0.75% expense ratio
Invesco QQQ Trust, Series 1 (QQQ) — 0.18% expense ratio
State Street Energy Select Sector SPDR ETF (XLE) — 0.08% expense ratio
WisdomTree Emerging Markets ESG Fund (DVEM) — 0.32% expense ratio
Goldman Sachs ActiveBeta Emerging Markets Equity ETF (GEM) — 0.59% expense ratio
State Street SPDR Dow Jones Industrial Average ETF Trust (DIA) — 0.16% expense ratio
State Street Technology Select Sector SPDR ETF (XLK) — 0.08% expense ratio

질문 및 답변

What is PRXV and what does it track?

The Praxis Impact Large Cap Value ETF (PRXV) is an actively managed ETF that seeks capital appreciation by investing in large-cap U.S. companies with value characteristics. It incorporates faith-based equity screens consistent with Praxis's stewardship investing core values.

What is the expense ratio for PRXV?

The expense ratio for PRXV is 0.36%. This means that for every $10,000 invested, the fund charges $36 annually to cover its operating expenses.

While this is a reasonable expense ratio, it's important to compare it to other large-cap value ETFs. The category average expense ratio for similar ETFs is approximately 0.44%, making PRXV relatively less expensive than its peers.

What are the top holdings in PRXV?

As of 2026-03-15, the top holdings in the Praxis Impact Large Cap Value ETF (PRXV) are: JPMorgan Chase & Co (3.50%), Johnson & Johnson (2.65%), and Walmart Inc (2.36%).

These companies represent a significant portion of the fund's total assets, reflecting the fund's concentrated investment approach. Other notable holdings include Procter & Gamble Co and Micron Technology Inc.

Is PRXV a good long-term investment?

Whether PRXV is a suitable long-term investment depends on individual investor goals and risk tolerance. The fund's focus on large-cap value stocks and its faith-based screening process may appeal to certain investors.

However, its concentrated portfolio and relatively small AUM should be considered. The fund's dividend yield is currently 0.00%. Past performance does not guarantee future results.

How does PRXV compare to similar ETFs?

PRXV distinguishes itself through its faith-based screening process, which may appeal to socially conscious investors. Its expense ratio of 0.36% is slightly lower than the category average.

However, its AUM of $0.05 billion is relatively small compared to more established large-cap value ETFs. Investors should compare PRXV's performance, holdings, and investment strategy against other value ETFs to determine the best fit for their portfolio.

Does PRXV pay dividends?

As of 2026-03-15, the Praxis Impact Large Cap Value ETF (PRXV) has a dividend yield of 0.00%. This indicates that the fund is not currently distributing dividends to its shareholders.

Investors seeking income-generating investments may want to consider other ETFs with a higher dividend yield.

면책 조항: 이 콘텐츠는 정보 제공만을 목적으로 하며 투자 조언을 구성하지 않습니다. 항상 자체 조사를 수행하고 재정 고문과 상담하십시오.

데이터는 정보 제공만을 목적으로 제공됩니다.

이 페이지는 기계가 작성했으며, 페이지별 사람 검수는 거치지 않았습니다. 편집 관리는 체계 차원에서 이루어집니다: 규칙과 출처를 점검하며, 개별 페이지는 점검하지 않습니다.